Published by IMARC Services Private Limited
Posted on September 13, 2021
5 min readLast updated: February 11, 2026
Add as preferred source on Google
According to the latest report by IMARC Group, titled “Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global vaccine market size reached US$ 41.4 Billion in 2020. On account of the aforementioned factors, the market is anticipated to grow at a CAGR of 8.2% during 2021-2026.
A vaccine stands for a biological component that stimulates antibody production against harmful pathogens in the body. It is typically produced by using disease-causing agents and chemical drugs acting as antigens for preventing diseases. Vaccines are mainly available as inactivated, conjugate, live attenuated, recombinant, and toxoid vaccines. They protect the body against a wide range of various life-threatening diseases, including polio, measles, diphtheria, meningitis, tetanus, etc. As a result, vaccines find widespread applications in several immunization procedures across numerous healthcare facilities and for research purposes in academic and clinical laboratories.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/vaccine-market/requestsample
Global Vaccine Market Trends and Drivers:
The increasing prevalence of several infectious diseases is one of the primary factors driving the market for vaccines. Moreover, the growing consumer awareness towards effective immunization for eradicating various infections is further augmenting the product demand. Additionally, the introduction of vaccination programs by government bodies across numerous endemic regions is further propelling the market growth. Furthermore, several global organizations, such as the WHO, UNICEF, Bill & Melinda Gates Foundation, etc., are launching adequate vaccination facilities across the developing and under-developed countries. Apart from this, the outbreak of the COVID-19 pandemic, since early 2020, has led to the development of novel vaccines to combat the risk of coronavirus infection. This is expected to further catalyze the growth of the global vaccine market in the coming years.
Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/vaccine-market
Key Market Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Breakup by Technology:
Breakup by Patient Type:
Breakup by Indication:
Breakup by Route of Administration:
Breakup by Product Type:
Breakup by Treatment Type:
Breakup by End User:
Breakup by Distribution Channel:
Breakup by Region:
Key highlights of the Report:
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Latest Market Research Reports by IMARC Group (2021-2026):
The global vaccine market size reached US$ 41.4 billion according to the latest report by IMARC Group.
The increasing prevalence of several infectious diseases and growing consumer awareness towards effective immunization are primary factors driving the market.
The report tracks both the direct and indirect effects of COVID-19 on the vaccine market, integrating these observations into the overall analysis.
The competitive landscape includes detailed profiles of key players operating in the market, although specific names are not provided in the excerpt.
If specific information is not currently included in the report, customization options are available to provide tailored insights.
Explore more articles in the Research Reports category
